Title:
トリアゾロトリアジン化合物およびそれらの使用
Document Type and Number:
Japanese Patent JP2007516206
Kind Code:
A
Abstract:
The present invention relates to compounds of the Formula (I), and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer
Inventors:
Zhang, Fan-Gee
Vozkovsky, Thomas
Huang pin
Lian, Kongsin
Doo, Steven High
Coenig, Marcel
Kui, Jinron
Vozkovsky, Thomas
Huang pin
Lian, Kongsin
Doo, Steven High
Coenig, Marcel
Kui, Jinron
Application Number:
JP2006518669A
Publication Date:
June 21, 2007
Filing Date:
June 25, 2004
Export Citation:
Assignee:
SUGEN,INC.
International Classes:
C07D487/04; A61K31/53; A61P1/00; A61P1/16; A61P1/18; A61P11/00; A61P13/08; A61P13/12; A61P15/00; A61P17/00; A61P19/00; A61P21/00; A61P25/00; A61P35/00; A61P35/02; A61P43/00
Attorney, Agent or Firm:
Kazuo Shamoto
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Shinobu Fukusho
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Shinobu Fukusho
Previous Patent: インドール、アザインドール、および関連するヘテロ環状Ｎ−置換ピペラ...
Next Patent: アルツハイマー病の治療のためのＮ−アルキルフェニルカルボキサミドβ...
Next Patent: アルツハイマー病の治療のためのＮ−アルキルフェニルカルボキサミドβ...